SciSight Ecosystem
SciSightAcademic Intelligence & JCR Rank
WoS SCIE Q1Hybrid

Female Pelvic Medicine and Reconstructive Surgery

Abbreviation (ISO):FEMALE PELVIC MED RE
Country: United States•WoS SCIE Quartile: Q1•Identifier (ISSN):2151-8378(Print)/2154-4212(Online)•Articles / Year: 246
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
22

22 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
246articles/year
2.32% Gold OA•97% Original Research

Aims & Scope

Female Pelvic Medicine & Reconstructive Surgery, official journal of the American Urogynecologic Society, is a peer-reviewed, multidisciplinary journal dedicated to specialists, physicians and allied health professionals concerned with prevention, diagnosis and treatment of female pelvic floor disorders. The journal publishes original clinical research, basic science research, education, scientific advances, case reports, scientific reviews, editorials and letters to the editor.

Topics Covered (Recognized by AI)
Medicine90.6%Surgery73.4%Biology62.2%Internal medicine61.5%Pathology52.2%Anatomy41.5%Urology35.8%Mathematics34.9%Radiology32.9%Statistics32.3%Genetics28.2%Endocrinology27.9%Urinary incontinence27.7%Psychology27.2%
Primary Research Areas
Obstetrics & Gynecology
Official WebsiteNLM PubMed CatalogSubmission Portal

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Language
English
Frequency
Periodic
Editorial Address
TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—13313
2025—152103
20241.4182357
20231.6144536
20221.913184913
20212.091132896
20201.5031911,791
20191.2371411,713
20181.3921451,729
2017—1562,540
2016—1221,810
2015—921,455
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Female Pelvic Medicine and Reconstructive Surgery

WoS Q1
012320182019202020212022202320241.40
Annual Impact Factor Metric
2024:1.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

71% MatchExplore →
69% MatchExplore →
69% MatchExplore →
Record UUID: 93b9b6ac-6709-4bd7-9d83-cf05aec0942e
Database Updated: 2026-09-29